IVA
$14.50
Inventiva S.A. ADR
$.26
1.83%
IVA
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  $0.00
Revenue:  N/A
Monday
Dec 20
4:10 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when IVA reports earnings?
Beat
Meet
Miss

Where is IVA's stock price going from here?
Up
Flat
Down
Stock chart of IVA
Analysts
Summary of analysts' recommendations for IVA
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Inventiva S.A. is a clinical-stage biopharmaceutical company. It is focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Inventiva S.A. is based in Daix, France.